Pharma Intelligence is part of the Informa Intelligence Division of Informa PLC
This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Senior Reporter Pharma Insights
USA
14+ years of experience
Pink Sheet
By Francesca Bruce 12 Oct 2021
The company behind the CVnCOV COVID-19 vaccine candidate says the decision to withdraw from regulatory review is strategic. The EMA says outstanding issues affecting the benefit-risk balance remained to be answered at the time of withdrawal.
Pink Sheet
By Francesca Bruce 30 Jun 2021
A delay to implementing drug pricing reforms is an opportunity for Canadian authorities to come up with better proposals, say industry representatives, while authorities remain adamant that action is necessary to lower prices.
Pink Sheet
By Francesca Bruce 27 Nov 2020
The Cancer Drugs Fund has improved access to oncology drugs, but if it is to remain fit for purpose it will need to evolve.
Topic Cancer
Pink Sheet
By Francesca Bruce 23 Nov 2020
England’s health technology appraisal body, NICE, and the UK medicines regulator, the MHRA, are working together to align their process timelines so that access to medicines is “maintained and enhanced.”
Topic Brexit Pharma-Brexit EU
Pink Sheet
By Francesca Bruce 21 Sep 2020
Germany is for the first time to adopt national guidelines on prescribing biologics and biosimilars in move towards increasing biosimilar uptake.
Topic EU Biosimilars
Pink Sheet
By Francesca Bruce 26 Aug 2020
The UK government has finally published its white paper on the UK’s future relationship with the EU following Brexit, to the relief of the pharmaceutical industry.
Topic Pharma-Brexit Brexit Regulation EU
Pink Sheet
By Francesca Bruce 29 Jul 2019
A national pharmacare program in Canada could make it harder to access higher cost drugs.
Topic Policy & Regulation
Pink Sheet
By Francesca Bruce 05 Jul 2019
Latin American joint price negotiations have proved successful and other countries are taking note.
Topic Business Strategies Deals
Pink Sheet
By Francesca Bruce 02 Jul 2019
Regulatory harmonization is gathering pace in Latin America, which is good news for pharmaceutical companies.
Topic Policy & Regulation
Pink Sheet
By Francesca Bruce 22 Aug 2018
PRIMA, the new service the National Institute for Health and Care Excellence offers to review economic models, must not be affected by confidentiality and conflict of interest issues, warns UK the pharmaceutical industry group, ABPI.
Topic Business Strategies
Pink Sheet
By Francesca Bruce 22 Aug 2018
The UK government has finally published its white paper on the UK’s future relationship with the EU following Brexit, to the relief of the pharmaceutical industry.
Topic Brexit
Pink Sheet
By Francesca Bruce 18 Jan 2018
The EU is once again facing criticism for its pursuit of investor-state dispute settlement-like mechanisms.
Pink Sheet
By Francesca Bruce 07 Dec 2017
Health technology assessment agencies are struggling to evaluate drugs on the basis of evidence generated for early approvals.
Topic BioPharmaceutical
Scrip
By Francesca Bruce 28 Mar 2017
In withdrawing its European marketing application for Translarna in cystic fibrosis, PTC Therapeutics has bid farewell to a market opportunity once pegged at $700m.
Pink Sheet
19 May 2022
Pink Sheet
13 May 2022
Pink Sheet
12 May 2022
Pink Sheet
05 May 2022
Pink Sheet
04 May 2022
Pink Sheet
28 Apr 2022
Pink Sheet
20 Apr 2022
Pink Sheet
07 Apr 2022
Pink Sheet
07 Apr 2022
Pink Sheet
01 Apr 2022
Pink Sheet
22 Mar 2022
Pink Sheet
17 Mar 2022
Pink Sheet
10 Mar 2022
Pink Sheet
09 Mar 2022
Pink Sheet
04 Mar 2022
